Fibronectin concentrations in the cerebrospinal fluid were assessed in 20 patients with acute meningitis using a turbidimetric immunoassay. A significant increase in fibronectin concentrations was observed in patients with bacterial meningitis; decreased concentrations were observed in patients with viral meningitis. The determination of fibronectin concentration in patients with bacterial meningitis may represent a useful marker in differentiating bacterial from viral meningitis.
Fibronectin is a large glycoprotein of the extracellular matrix with a molecular weight of about 420. It is found in virtually all body tissues and fluids, and is involved in adhesion and phagocytosis.' Adhesion is a mandatory step for leucocytes passing through the vascular endothelia and migrating to the site of inflammation. There are two major forms of fibronectin: one is found in the blood (circulating fibronectin); and the other is associated with the cell surface (cellular fibronectin). Kuusela et Twenty five healthy normal subjects (13 men and 12 women, mean (SEM) age 35-2 (20 1) years) served as control group.
The fibronectin concentration in cerebrospinal fluid was determined by using a turbidimetric immunoassay (Boehringer Biochemica, Mannheim, Germany). Turbidimetric measurement of the antigen-antibody reaction was performed according to the principle of the end-point method. Samples from a given patient were all analysed at the same time and made in duplicate.
Data are expressed as mean and standard deviation. Data were evaluated by the MannWhitney U test. The level of significance was 5%.
Results
The results of this study are illustrated in the figure. The cerebrospinal fluid concentrations of fibronectin in patients with bacterial meningitis were significantly higher (13 9 (6-1) mg l-l; p < 0-01) than those of the control group (6-7 (1-3) mg 1-l). On the other hand, the 
Discussion
This study shows that the determination of fibronectin in the cerebrospinal fluid may be of diagnostic value in differentiating bacterial from viral meningitis. In fact, a clear difference was observed between the concentration in patients with bacterial meningitis and in those with aseptic meningitis. Although the origin of fibronectin in the cerebrospinal fluid is not clear, several hypotheses could explain the increased concentrations of this protein in bacterial meningitis. The presence of fibronectin in the cerebrospinal fluid is at least partially the result of local production in the central nervous system. It seems feasible that fibronectin may be synthesised intrathecally as a reaction of tissue damaged by the infective process. Polymorphonuclear neutrophils are the major cell population in the acute inflammatory reaction of bacterial meningitis. Polymorphonuclear neutrophils can respond to a variety of stimuli and, on activation, emerge from the circulation and migrate to inflammed meninges. Furthermore, polymorphonuclear neutrophils retain the capacity to synthesise RNA and proteins in the nonactivated and activated states.4 La Fleur et al observed that fibronectin and its mRNA are synthesised by polymorphonuclear neutrophils, especially under conditions of activation. 5 Kreis et al also showed that polymorphonuclear neutrophils isolated from the synovial fluid of patients with inflammatory arthropathies synthesise and secrete increased amounts of fibronectin.6 De novo synthesis of fibronectin by polymorphonuclear neutrophils accumulated in the cerebrospinal fluid of patients with bacterial meningitis may be responsible for the increased cerebrospinal fluid concentrations. On the other hand, fibronectin binds to Staphylococcus aureus, Lancefield group A, C, and G streptococci, Streptococcus sanguis and Streptococcus pneumoniae.7 In this study, none of the cases of meningitis was produced by organisms that have previously been shown to bind fibronectin. It is conceivable, however, that fibronectin may bind to several other Gram positive and some Gram negative organisms. On the basis of our results, we are not able to determine whether binding of fibronectin by organisms isolated in our patients would result in lower cerebrospinal fluid concentrations.
The decreased concentrations of fibronectin observed in patients with aseptic meningitis could be due to the binding of fibronectin to viral proteins or to the virus itself. In fact, Julkunen et al showed that the glycoproteins of influenza A, parainfluenza 1, and mumps viruses bound efficiently to fibronectin.'0 As accumulation of polymorphonuclear neutrophils in the cerebrospinal fluid of patients with viral meningitis is rarely observed, de novo synthesis of fibronectin by polymorphonuclear neutrophils is probably not a factor. Thus fibronectin could represent a useful marker for differentiating bacterial from viral meningitis. Further studies will be needed, however, to clarify the role of fibronectin in the host response against bacterial or viral pathogens responsible for meningitis. 
